Main Article Content

Abstract

Background: Lupus nephritis is defined as renal involvement in systemic lupus erythematosus (SLE) patients and the most important cause of morbidity and mortality. The diagnostic criteria that used to diagnose lupus nephritis are 1997 American College
of Rheumatology is 24 hours urine protein ≥500 mg and/or cellular cast, but significant renal damage can occur without proteinuria or cellular cast. Anti-C1q is an autoantibody that is produced by a chronic alteration of C1q collagen domain. Anti-C1q is a new specific marker for renal marker.

Objective: To determine the validity of anti-C1q serum by using 1997 American College of Rheumatology criteria as a gold standard. 

Methods: This is a cross sectional study, conducted in October to December 2014 at Hasan Sadikin Hospital Bandung. The subjects had systemic lupus erythematosus with and without renal involvement, based on 1997 American College of Rheumatology criteria for SLE.

Results: There were 65 subjects included in this study, 64 subjects were female and 1 subject was male. The age average was 32 (SD 11.7) years old. As many as 66.2% subjects had been diagnosed with lupus erythematosus systemic at least 3 years. Twenty four hours urine protein was measured using spectrophotometry, urine sediment was examined
for cellular cast, and anti-C1q serum was measured using micro enzyme linked immunosorbent assay. Based on American College of Rheumatology criteria, 34 subjects were classified as lupus nephritis group while 31 subjects were classified as non-lupus nephritis group. The area under the curve of anti-C1q was 0.610. The cut-off value used in this study was 10.43 U/ml. The sensitivity, specificity, positive predictive value,
negative predictive value and accuracy of anti-C1q assay were 41.18%, 77.42%, 66.67%, 54.55% and 58.46% respectively.
Conclusion: Anti-C1q assay, based on this study, has
a low sensitivity and medium specificity to detect lupus
nephritis

Article Details

How to Cite
Enrica, M., Tjandrawati, A., Rachmayati, S., & Hamijoyo, L. (2018). Validity test of anti-c1q serum as diagnostic marker for lupus nephritis. Indonesian Journal of Rheumatology, 8(1). https://doi.org/10.37275/ijr.v8i1.8

References

  1. Kasjmir YI, Handono K, Wijaya LK, Hamijoyo L, Albar Z, Kalim H. Rekomendasi Perhimpunan Reumatologi Indonesia Untuk Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik. Jakarta: Perhimpunan Ahli Penyakit Dalam Indonesia; 2011.
  2. Hahn BH, McMahon MA, Wilkinsil A, Wallace WD, Daikh DI, Fitzgerald JD, et al. American College of Rheumatology Guidelines for Screening, Treatment, and Management of Lupus Nephritis. Arthritis Care & Research 2012;64(6):797-808.
  3. Salgado AdZ, Herrera-Diaz C. Lupus Nephritis: An overview of recent findings. Autoimmune Diseases 2012;2012:1-21.
  4. Yazdany J, Dall’Era M. Definition and Classification of Lupus and LupusRelated Disorders. In: Wallace DJ, Hahn BH, editors. Dubois’ Systemic Lupus Erythematosus and Related Syndrome. 8th ed. Philadelphia: Elsevier Saunders; 2013. p. 1-3.
  5. Mahler M, Schaarenburg RAV, A.Trouw L. Anti-C1q autoantibodies, novel tests, and clinical consequences. Front Immunol 2013;4:117.
  6. Pickering MC, Botto M. Are anti-C1q antibodies different from other SLE autoantibodies?. Nat Rev Rheumatol 2010;6:490-3.
  7. Moura CGG, Mangueira CLP, Cruz LAS, Cruz CMS. Negative anti-C1q Antibody Titers May Influence Therapeutic Decisions and Reduces Renal Biopsies in Systemic Lupus Erythematosus. Nephron Clin Pract. 2011;18:355-60.
  8. Meyer OC, Roland PN, Cadoudal N, Mignot SG, Palazzo E, Hayem G, et al. Anti-C1q antibodies antedate patent active glomerulonephritis in patients with systemic lupus erythematosus. Arthritis Research & Therapy 2009 (11):1-8.
  9. Katsumata Y, Miyake K, Kawaguchi Y, Okamoto Y, Kawamoto M, Gono T, et al. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis. Arthritis Rheum 2011;63(8):2436-44.
  10. Heidenreich U, Mayer G, Herold M, Klotz W, Stempfl K, Al-Jazrawi, et al. Sensitivity and specificity of autoantibody tests in the differential diagnosis of lupus nephritis. Lupus. 2009;18:1276-80.
  11. Lehman TJA. SLE in Childhood and Adolescence. In: Wallace DJ, Hahn BH, editors. Dubois’ Systemic Lupus Erythematosus and Related Syndrome. 8th ed. Philadelphia: Elsevier Saunders; 2013. p. 495-7.
  12. Dooley MA. Clinical and epidemiologic features of lupus nephritis. In: Wallace DJ, Hahn BH, editors. Dubois’ Lupus Erythematosus and Related Syndrome. 8th ed. Philadelphia: Elsevier Saunders; 2013. p. 438-52.
  13. Chong BF, Werth VP. Skin Disease in Cutaneous Lupus Erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois’ Systemic Lupus Erythematosus and Related Syndrome. 8th ed. Philadelphia: Elsevier Saunders; 2013. p.319-30.
  14. Navarra SV, Torralba TP. The Musculoskeletal System and Bone Metabolism. In: Wallace DJ, Hahn BH, editors. Dubois’ Systemic Lupus Erythematosus and Related Syndrome 8th ed. Philadelphia: Elsevier Saunders; 2013. p. 333-8.
  15. Ishimori M, Weisman MH, Katy Setoodeh, Wallace DJ. Principles of Therapy, Local Measures, and Nonsteroidal Medications. In: Wallace DJ, Hahn BH, editors. Dubois’ Lupus Erythematosus and Related Syndrome. 8th ed. Philadelphia: Elsevier Saunders; 2013. p. 583.
  16. Hegazy A, Barakat AF, Gayyar MAE, Arafa LF. Prevalence and clinical significance of anti-C1q antibodies in cutaneous and systemic lupus erythematosus. The Egyptian Journal of Medical Human Genetics 2012;13:167-71.
  17. Cai X, Yang X, Lian F, Lin X, Liang M, Li J, et al. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis. J Rheumatol. 2010;37:759-65.
  18. Mannik M, Wener M. Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis. Arthritis Rheum. 1997;40:1504-11.
  19. Christopher-Stine L, Siedner M, Lin J, Haas M, Parekh H, Petri M. Renal Biopsy in Lupus Patients with Low Levels of Proteinuria. J Rheumatol 2007;34:332-5.
  20. Vargas-Arenas RE, Tápanes F, Daboin I, Pinto JA, Bianco NE, ZabaletaLanz M. Silent Lupus Nephritis. Inmunología. 2004;23(3):278-83.